9.9%; p =0.002; Figure 2). Note that patients randomized to combination therapy who were titrated to losartan 100 mg/HCTZ 25 mg at Week 2 for safety reasons were not considered to have achieved ...
[62] After a 4-week placebo run-in period, patients were randomized to receive either placebo, nebivolol 1, 5 or 10 mg once daily, or HCTZ 12.5 or 25 mg once daily, or one of six possible ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results